Weight Loss · Provider Directory · Updated 2026-05-11

Weight Loss Peptides & Telehealth Providers

Semaglutide, tirzepatide, and other GLP-1 receptor agonists are the cornerstone pharmacotherapy for chronic weight management in 2026. This category covers FDA-approved brand options (Wegovy, Zepbound), compounded telehealth pathways, and emerging molecules (retatrutide, orforglipron).

6 peptides covered v3.0 rubric Updated 2026-05-11 All 50 states + DC
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-05-11

Peptides in this category

Editor’s Pick — semaglutide & tirzepatide

Editor’s Pick — Tirzepatide Category

Top telehealth providers for weight loss

See the full provider directory for complete profiles, pricing, and v3.0 transparency scoring.

Editorial team

Reviews authored by Dr. Sam Saberian (Lead Medical Researcher), medically reviewed by Alen A. Schwartz, MD, and edited by Julliana Edwards (Editor). About our team →

Related categories